|
Market Closed -
Bombay S.E.
06:02:20 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 957.00 INR | +1.21% |
|
-4.60% | +6.06% |
Company Valuation: Strides Pharma Science Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 31,121 | 25,858 | 72,114 | 61,675 | 86,435 | 88,255 | - |
| Change | - | -16.91% | 178.88% | -14.47% | 40.15% | 2.11% | - |
| Enterprise Value (EV) | 31,121 | 25,858 | 72,114 | 61,675 | 86,435 | 88,255 | 88,255 |
| Change | - | -16.91% | 178.88% | -14.47% | 40.15% | 2.11% | 0% |
| P/E | -6.76x | -12.7x | -101x | 1.71x | 15.5x | 14.1x | 10x |
| PBR | 1.32x | 1.19x | 3.39x | - | 2.78x | 2.38x | 1.96x |
| PEG | - | 0.2x | 1.5x | -0x | -0.2x | 1.1x | 0.2x |
| Capitalization / Revenue | 1.01x | 0.7x | 1.78x | 1.35x | 1.78x | 1.52x | 1.28x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.52x | 1.28x |
| EV / EBITDA | -0x | 0x | 0x | 0x | 0x | 7.9x | 6.3x |
| EV / EBIT | -0x | 0x | 0x | - | 0x | 9.97x | 8.07x |
| EV / FCF | -0x | -0x | 0x | 0x | 0x | 18.4x | 13.4x |
| FCF Yield | -12.9% | -1.95% | 8.08% | 7.16% | 3.29% | 5.44% | 7.44% |
| Dividend per Share 2 | - | 1.5 | 2.5 | - | 5 | 3 | 3 |
| Rate of return | - | 0.52% | 0.32% | - | 0.53% | 0.31% | 0.31% |
| EPS 2 | -51.28 | -22.49 | -7.76 | 390.5 | 60.34 | 68.1 | 95.4 |
| Distribution rate | - | -6.67% | -32.2% | - | 8.29% | 4.41% | 3.14% |
| Net sales 1 | 30,702 | 36,884 | 40,511 | 45,653 | 48,587 | 58,230 | 69,123 |
| EBITDA 1 | -103.2 | 4,302 | 7,433 | 8,028 | 9,253 | 11,173 | 14,014 |
| EBIT 1 | -2,531 | 1,869 | 5,226 | - | 7,229 | 8,850 | 10,940 |
| Net income 1 | -4,602 | -2,026 | -706.1 | 35,935 | 5,562 | 6,277 | 8,798 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 346.60 | 286.35 | 784.70 | 669.20 | 937.75 | 957.50 | 957.50 |
| Nbr of stocks (in thousands) | 89,790 | 90,303 | 91,900 | 92,163 | 92,173 | 92,173 | - |
| Announcement Date | 5/24/22 | 5/25/23 | 5/22/24 | 5/22/25 | 5/18/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 34.6x | 6.48x | 22.46x | 0.91% | 46.96B | ||
| 18.37x | 2.19x | 9.9x | 1.41% | 39.63B | ||
| 27.86x | 3.39x | 17.55x | 0.91% | 12.07B | ||
| 26.75x | 3.83x | 15.86x | 0.61% | 11.61B | ||
| 18.73x | 3.33x | 11.58x | 3.85% | 9.11B | ||
| 9.06x | 2.09x | 5.45x | 4.44% | 7.47B | ||
| 15.9x | 2.07x | 6.73x | 3.21% | 7.18B | ||
| 28.04x | 3.66x | 17.01x | 0.17% | 6.79B | ||
| Average | 22.41x | 3.38x | 13.32x | 1.94% | 17.6B | |
| Weighted average by Cap. | 25.15x | 3.99x | 15.29x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- STAR Stock
- STAR Stock
- Valuation Strides Pharma Science Limited
Select your edition
All financial news and data tailored to specific country editions
















